2617 — TransThera Sciences (Nanjing) Cashflow Statement
0.000.00%
Last trade - 00:00- HK$17.00bn
- HK$16.44bn
Annual cashflow statement for TransThera Sciences (Nanjing), fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | ARS |
| Standards: | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final |
| Net Income/Starting Line | -343 | -275 | -296 |
| Depreciation | |||
| Amortisation | |||
| Non-Cash Items | -19.1 | 3.34 | 8.64 |
| Unusual Items | |||
| Other Non-Cash Items | |||
| Changes in Working Capital | 35.7 | -6.35 | 28.8 |
| Change in Inventories | |||
| Change in Prepaid Expenses | |||
| Change in Accounts Payable | |||
| Change in Other Liabilities | |||
| Other Operating Cash Flow | |||
| Cash from Operating Activities | -319 | -271 | -254 |
| Capital Expenditures | -11.8 | -0.773 | -0.164 |
| Purchase of Fixed Assets | |||
| Purchase / Acquisition of Intangibles | |||
| Other Investing Cash Flow Items | -175 | 349 | -67.8 |
| Sale of Fixed Assets | |||
| Sale/Maturity of Investment | |||
| Purchase of Investments | |||
| Other Investing Cash Flow | |||
| Cash from Investing Activities | -187 | 348 | -68 |
| Financing Cash Flow Items | -0.734 | -1.64 | -0.525 |
| Other Financing Cash Flow | |||
| Net Issuance / Retirement of Stock | |||
| Net Issuance / Retirement of Debt | |||
| Cash from Financing Activities | 15.8 | -4.87 | 169 |
| Foreign Exchange Effects | |||
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | -487 | 72.9 | -154 |